Needham & Company LLC Issues Pessimistic Forecast for Vital Farms (NASDAQ:VITL) Stock Price

Key Points

• Needham cut its Vital Farms price target from $14 to $13 but maintained a Buy rating, implying about 29.7% upside from the stock’s current price.
• Analyst views are mixed: six rate the stock Buy, seven Hold and one Sell; the consensus rating is Hold with a $16.45 target.
• Vital Farms’ latest quarter missed earnings expectations, reporting a $0.15-per-share loss versus an expected $0.11 loss. Revenue was near forecasts at $182.2 million but fell 8.4% year over year.

Vital Farms (NASDAQ:VITL - Get Free Report) had its price objective cut by stock analysts at Needham & Company LLC from $14.00 to $13.00 in a report issued on Wednesday, Benzinga reports. The firm presently has a "buy" rating on the stock. Needham & Company LLC's target price points to a potential upside of 29.74% from the stock's current price.

Several other research analysts also recently commented on the company. Benchmark raised Vital Farms from a "hold" rating to a "buy" rating in a research note on Thursday, August 6th. TD Cowen lowered their target price on shares of Vital Farms from $11.00 to $8.00 and set a "hold" rating on the stock in a research note on Tuesday, October 13th. Weiss Ratings lowered shares of Vital Farms from a "sell (d+)" rating to a "sell (d)" rating in a report on Tuesday, September 29th. Craig Hallum raised shares of Vital Farms from a "hold" rating to a "buy" rating and set a $12.00 target price for the company in a report on Tuesday. Finally, BMO Capital Markets restated an "outperform" rating on shares of Vital Farms in a research report on Wednesday. Six equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Vital Farms has an average rating of "Hold" and a consensus target price of $16.45.

Vital Farms Price Performance

NASDAQ:VITL opened at $10.02 on Wednesday. The stock has a 50 day moving average of $9.73 and a two-hundred day moving average of $13.96. Vital Farms has a 12 month low of $7.95 and a 12 month high of $38.64. The firm has a market cap of $430.16 million, a P/E ratio of -250.50 and a beta of 1.16. The company has a current ratio of 1.10, a quick ratio of 0.60 and a debt-to-equity ratio of 0.11.

Vital Farms (NASDAQ:VITL - Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.04). The firm had revenue of $182.16 million during the quarter, compared to analysts' expectations of $181.78 million. Vital Farms had a net margin of 0.02% and a return on equity of 3.46%. The business's revenue was down 8.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.36 EPS. On average, analysts expect that Vital Farms will post -0.53 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Vital Farms

A number of institutional investors have recently bought and sold shares of VITL. Allspring Global Investments Holdings LLC lifted its position in Vital Farms by 11.4% in the first quarter. Allspring Global Investments Holdings LLC now owns 14,102 shares of the company's stock valued at $199,000 after buying an additional 1,438 shares during the last quarter. Keebeck Wealth Management increased its position in shares of Vital Farms by 16.5% during the first quarter. Keebeck Wealth Management now owns 10,707 shares of the company's stock valued at $151,000 after acquiring an additional 1,513 shares during the last quarter. Raiffeisen Bank International AG increased its position in shares of Vital Farms by 8.0% during the second quarter. Raiffeisen Bank International AG now owns 27,000 shares of the company's stock valued at $305,000 after acquiring an additional 2,000 shares during the last quarter. Assetmark Inc. increased its position in shares of Vital Farms by 53.7% during the first quarter. Assetmark Inc. now owns 5,732 shares of the company's stock valued at $81,000 after acquiring an additional 2,002 shares during the last quarter. Finally, Signaturefd LLC raised its stake in shares of Vital Farms by 53.6% in the 3rd quarter. Signaturefd LLC now owns 5,829 shares of the company's stock valued at $54,000 after acquiring an additional 2,035 shares during the period. 98.59% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Vital Farms

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Craig Hallum upgraded VITL from “hold” to “buy” and set a $12 price target, citing potential upside from the share price reported at the time. Craig Hallum rating
• Negative Sentiment: Q3 results showed a loss of $0.15 per share, worse than the roughly $0.11–$0.13 loss expected, versus earnings of $0.36 a year earlier. Revenue was about $182.2 million—near analyst estimates—but down 8.4% year over year. Q3 results
• Negative Sentiment: Vital Farms expects approximately $730 million in 2026 net sales but an adjusted EBITDA loss of about $15 million, and withdrew its 2030 targets. The weaker profitability outlook and reduced long-term visibility weigh on the investment case. 2026 outlook
• Negative Sentiment: A report also flagged litigation and accounting/financial-operations risks amid volatile egg markets, adding uncertainty for investors. Risk report

Vital Farms Company Profile

Vital Farms, Inc is a food company that produces and markets pasture-raised eggs and other ethically sourced food products. Its offerings include pasture-raised eggs, butter, hard-boiled eggs and ghee, sold under the Vital Farms brand.

Founded in 2007, the company works with a network of family farms and focuses on animal welfare, outdoor access and supply-chain transparency. Vital Farms products are distributed primarily through grocery retailers and other food channels across the United States.

Vital Farms is headquartered in Austin, Texas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.